Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19
Clinical trial NCT04634799 · SUSPENDED
Trial details
- NCT number
- NCT04634799
- Sponsor
- Northwestern University
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2025-04-23
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.